Anthropic IPO Date and Price: What Is Confirmed, What Is Reported, and What Is Still Unknown

Anthropic IPO Date: The Current Expected Window

There is no announced Anthropic IPO date. That is the honest answer, and every page telling you otherwise is presenting a reported expectation as a scheduled event. What Anthropic itself has stated publicly is narrow: on June 1, 2026, Anthropic, PBC confidentially submitted a draft registration statement on Form S-1 to the United States Securities and Exchange Commission for a proposed initial public offering of its common stock, and the number of shares and the price range had not been determined. That announcement was made under Rule 135 of the Securities Act, which is the specific mechanism that lets a company acknowledge a planned offering without the acknowledgement itself constituting an offer to sell.

Everything past that sentence comes from reporting. On September 4, 2026, Reuters reported that Anthropic is expected to begin marketing its offering in mid-October at the earliest and to complete the listing days before the United States midterm elections in November. The same reporting said the public prospectus — previously expected in the week of September 7 — had slipped to late September 2026. Those sources cautioned that plans, including timing, remain subject to change. That timetable has since moved: on September 18, 2026, The Wall Street Journal reported that Anthropic pushed the listing from October to November.

Confirmed by Anthropic

Confidential draft Form S-1 submitted to the SEC on June 1, 2026. No share count, no price, no date, no exchange, no ticker.

Public prospectus

Not filed as of September 27, 2026 (we re-checked SEC EDGAR full-text search that day: no S-1, S-1/A or pricing prospectus from Anthropic, PBC). It had been expected in late September (Reuters, Sept 4); with the listing moved to November, it can come later.

Roadshow

Not scheduled. It must come at least 15 days after the S-1 is made public, and the WSJ reports the company wants third-quarter results in hand first.

Listing expected

November 2026, pushed back from October (The Wall Street Journal, Sept 18, 2026). On Polymarket on Sept 26, traders gave 24% odds of a listing by Nov 15, 58% by Nov 30 and 77% by Dec 31.

Reported deal size

Up to US$100 billion at a valuation of about US$2 trillion (WSJ). Anthropic expects its annualized revenue run rate to top US$110 billion by year-end.

Exchange

Nasdaq is widely expected (91.8% on Polymarket, Sept 26) but has not been confirmed by Anthropic.

Voting control

The Information reported on Sept 25 that Anthropic's seven co-founders want a new share class giving them 50.1% of the vote while owning about 14% of the company.

Status of the price

Not set. No range has been filed publicly.

The mechanical constraint worth knowing is the fifteen-day rule. A company that files confidentially must publicly file its registration statement, including the original draft and any amendments, at least fifteen days before it begins the roadshow. That rule is why "public prospectus in late September" and "roadshow mid-October" fit together: the fifteen-day clock is the shortest possible bridge between the two. If the prospectus does not appear by the end of September, the mid-October roadshow window moves with it, and so does the listing. That is what happened: the prospectus did not appear in September, and the listing is now reported for November.

One more sequencing detail matters. Reuters reported that Anthropic is working to finalise a $15 billion revolving credit facility before analyst meetings begin. Credit facilities of that size close before a roadshow, not during one, because underwriters and lenders both need final terms locked before public investor conversations start. If you want a single leading indicator for whether the November window holds, that facility closing is a better one than any rumoured date.

How to read any Anthropic IPO date you see online. Until a public S-1 or S-1/A appears in SEC EDGAR, there is no filed date, no filed price range and no filed ticker. Prediction markets, secondary-market platforms and data vendors will all display numbers — those are estimates, order-book prices or placeholders, not terms of an offering.

Anthropic IPO Price and Share Price Estimates

The Anthropic IPO price does not exist yet, and it will not exist until the very end of the process. Here is the actual order of operations, and where every number currently circulating sits within it.

The share price numbers currently in circulation

Two cautions on the per-share figure specifically. First, private-market estimates are built on a share count that can change materially before listing — stock splits, new grants, converted instruments and the offering itself all move the denominator. Second, a company that lists at a $2 trillion market capitalisation does not need a high per-share price to get there; the offer price is a function of how the share count is set, which is a decision Anthropic and its underwriters make late in the process. Treat any confident "Anthropic will price at $X per share" claim published before the amended S-1 as content marketing.

Full Anthropic IPO Timeline: December 2025 to Today

Anthropic Valuation: From $965 Billion to a Possible $2 Trillion

Anthropic's private valuation history is one of the steepest on record. The company was worth roughly US$623 million at its Series A in May 2021. Five years later its Series H landed at approximately US$965 billion. That is a re-rating of more than 1,500 times in five years, and it is the single most important context for why pricing this IPO is difficult.

The bull case for the $2 trillion figure rests on forward revenue rather than trailing revenue. Reports suggest Anthropic's 2028 revenue projections sit in the range of US$190–200 billion. A $2 trillion listing against roughly $200 billion of 2028 revenue is about a 10x forward multiple on a number three years out — aggressive, but not unprecedented for a company compounding the way this one has. Against the current run rate, the same $2 trillion is closer to 30x, which is where the argument gets contested.

The bear case is simpler and rests on three things: gross margin, capital intensity, and comparables. Anthropic's gross margin has been reported around 40% with a stated ambition to reach the mid-to-high seventies by 2028 — margin expansion that has to survive relentless compute purchasing. Cash-flow breakeven has been pushed toward 2028. And the sceptics' favourite comparable is C3.ai, which popped on AI enthusiasm in December 2020 and then fell roughly 88% from its highs as losses persisted and sales cycles stretched. Whether that comparison is fair for a company with 8 of the Fortune 10 as customers is exactly the argument the roadshow will be about.

The Financials Underwriting the Number

Revenue growth is the reason this deal exists at this size. The reported run-rate progression is unusual enough to be worth laying out plainly, because it is the number every buy-side desk is modelling against.

One detail that cuts against the usual IPO narrative: Anthropic does not obviously need the money. The company has raised more than US$125 billion privately, covers operating costs from revenue, and holds more cash than most listed companies. Reporting suggests the listing is as much about liquidity for early investors and employees, a public valuation mark, and audited-financial credibility with enterprise and government buyers as it is about raising capital. That framing matters for how the deal gets priced, because a company that does not need the proceeds can walk away from a soft book.

Anthropic Ticker Symbol, Exchange and Listing Mechanics

Anthropic has not announced a ticker symbol or an exchange. Search interest in "Anthropic stock symbol" and "Anthropic ticker" is enormous right now, and the search results are misleading for a specific technical reason: market-data providers create pre-listing placeholder pages for anticipated IPOs, and those pages need a string in the symbol field. Strings such as ANTHRO and ANTHROPIC currently appear on vendor pages. They are placeholders, not allocated tickers.

The exchange is a similar story. Nasdaq is widely reported as the expected venue and is the conventional choice for a company of this profile, but Anthropic has not confirmed it. Both the exchange and the symbol become official in the public registration statement and the corresponding exchange listing notice — the same document that will finally contain the price range.

If you want to track this yourself rather than through aggregators, there are exactly two authoritative sources: the SEC's EDGAR full-text search for an Anthropic S-1 or S-1/A, and Anthropic's own investor communications. Anything published ahead of those two is derivative.

What to watch, in order:

1. The US$15 billion revolving credit facility closing. 2. Analyst meetings convened by the syndicate banks. 3. A public S-1 or S-1/A appearing in EDGAR. 4. An amended filing carrying the indicative price range and share count. 5. Roadshow launch. 6. Pricing night — the first and only real Anthropic IPO price.

How to Buy Anthropic Stock — and the Pre-IPO Warning

Until Anthropic lists, its shares cannot be bought through an ordinary brokerage account anywhere, including in Canada. That fact has created a market for products claiming to offer pre-IPO exposure, and this is the part of the story where retail investors are most exposed.

The legitimate routes, and their limits

Risk Factors to Expect in the Anthropic S-1

The risk factors section of a prospectus is where the marketing stops. Based on reporting to date, here is what the Anthropic S-1 is likely to disclose — and what a serious reader should look for first when it lands.

AI backlash as a named risk. CNBC reported in August 2026 that the filing will explicitly list public and political backlash against AI as a risk factor. That is notable because it is a reputational and regulatory risk rather than an operational one, and it is unusual to see it named that directly.

Competition. OpenAI and Google are the obvious named competitors. The open-weight model ecosystem is the less obvious one — pricing pressure from capable open models compresses margins at the commodity end of the market even when it does not touch frontier contracts.

Litigation. Reporting points to music copyright lawsuits and a favourable ruling relating to a Pentagon designation. Copyright exposure is the structural legal question for every frontier lab, and the disclosure language will be read closely.

Capital intensity and margin. Roughly US$19 billion of 2026 compute spend against a reported ~40% gross margin, with the investment case requiring expansion toward the mid-seventies by 2028. Every dollar of that expansion is contested by the cost of the next model generation.

Customer concentration. Eight of the Fortune 10 and 500-plus enterprise customers at seven figures is a strong roster, but concentrated revenue is concentrated risk. The S-1's concentration table is worth reading before the growth chart.

Governance. The Long-Term Benefit Trust holds no equity yet can appoint a majority of the board. Public shareholders will be buying into a structure that deliberately limits shareholder primacy. Whether that is a feature or a discount is a genuine open question, and different investors will answer it differently.

Supply of mega-deals. Anthropic is not listing into an empty market. SpaceX priced in June 2026 at roughly US$1.77 trillion, ran up on a thin float, and then repriced sharply lower after its first earnings report forced investors to re-underwrite its AI capital spending. That precedent is fresh, and it is about capital-spending disclosure specifically — which makes it directly relevant here.

Anthropic vs OpenAI vs SpaceX: The 2026 IPO Queue

The SpaceX outcome is the most instructive data point available. It priced at a record, traded up hard on a small float, and then gave back a large share of the gain once its first public earnings report made investors price in its AI capital spending rather than imagine it. Anthropic will list into a market that has now seen that movie once. Its prospectus will be read with the SpaceX repricing in mind, which is one reason the disclosure of compute commitments and margin trajectory is likely to matter more to the final price than the revenue chart everyone is currently quoting.

On OpenAI: the crowded-queue narrative from earlier in 2026 has thinned considerably. Reporting through mid-2026 pointed toward a 2027 listing, with CFO Sarah Friar having told employees the company will be public in 2027 if not sooner. Prediction-market pricing for a 2026 OpenAI listing fell to roughly 18% over the same period. If that holds, Anthropic lists without a direct frontier-lab comparable trading alongside it — which cuts both ways for pricing.

Why This Listing Matters If You Are Costing an AI Data Centre

Strategic Crypto Reserve covers the Anthropic IPO for one reason: the number underneath it is a compute number. Roughly US$19 billion of 2026 compute spend, an US$80 billion capacity commitment in a single week, and a margin trajectory that only works if inference gets cheaper — that is a data centre story wearing an equity story's clothes.

Every dollar of frontier-lab capital expenditure lands as racks, power contracts, cooling and interconnect somewhere. The public prospectus will be the most detailed disclosure yet published on how a frontier lab actually allocates that spend, and it will reset the reference numbers that everyone downstream — colocation operators, regional developers, independent builders — uses to justify a build. If you are modelling a site, the S-1 is worth reading as an infrastructure document, not only a financial one.